All-oral 12-week treatment with daclatasvir plus sofosbuvir in patients with hepatitis C virus genotype 3 infection: ALLY-3 phase III study.
Hepatology
; 61(4): 1127-35, 2015 Apr.
Article
in En
| MEDLINE
| ID: mdl-25614962
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Antiviral Agents
/
Uridine Monophosphate
/
Hepatitis C
/
Hepacivirus
/
Imidazoles
Limits:
Adult
/
Aged
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Hepatology
Year:
2015
Document type:
Article